Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 ataluren study in nonsense mutation cystic fibrosis
NL-OMON44153Phase 3Active, not recruiting
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ataluren in cystic fibrosis (CF), sponsored by PTC Therapeutics, Inc.. Started Jun 2015; status: active, not recruiting.
02
Drugs
ataluren
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON44153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44153.